Source: Eur Respir J 2005; 25: 902-910
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Sable S. B., Verma I., Behera D., Khuller G. K.. Human immune recognition-based multicomponent subunit vaccines against tuberculosis. Eur Respir J 2005; 25: 902-910

Member's Comments

No comment yet.

Related content which might interest you: State of the art in vaccine development against TB Source: Eur Respir Mon 2012; 58: 59-71 Year: 2012 Mucosal immunity and novel vaccines against tuberculosis Source: Lung Science Conference 2015 Year: 2015 Towards a new vaccine for tuberculosis Source: Eur Respir Monogr 2018; 82: 343-363 Year: 2018 Humoral immune response against 38-kDa and 16-kDa mycobacterial antigens in tuberculosis Source: Eur Respir J 2007; 29: 143-148 Year: 2007 A novel TNF inhibitor does not compromise host immunity to mycobacterium tuberculosis and BCG infections and still protects from hepatitis Source: Annual Congress 2009 - Clinical immunology of tuberculosis Year: 2009 Does BCG revaccination lead to enhanced protective immunity against tuberculosis? A study using surrogate markers Source: Annual Congress 2005 - Epidemiology and control of tuberculosis and LTBI Year: 2005 BCG vaccination in childhood is not related to pulmonary immunity against M. tuberculosis in adults Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments Source: Eur Respir Rev 2015; 24: 356-360 Year: 2015 Pneumococcal and influenza vaccination Source: Respipedia Article Year: 2018 Design of immunogenic multiepitopic mycobacterium tuberculosis peptides from genes selected using in vitro models of mycobacterial macrophage infection Source: Eur Respir J 2007; 30: Suppl. 51, 493s Year: 2007 Protective capacity of a new TB vaccine Source: International Congress 2018 – New developments in tuberculosis Year: 2018 The protective effect of BCG vaccination against mycobacterium tuberculosis infection in children: A systematic review Source: International Congress 2014 – Tuberculosis: public health and primary prevention Year: 2014 Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults Source: Eur Respir J 2014; 44: 1087-1090 Year: 2014 Unique cytokine profiles of CD4+T cell to Acr, HBHA and MDP-1 antigens in different clinical stage of mycobacterium tuberculosis infection Source: International Congress 2014 – Future frontiers in the diagnosis of Mycobacterium tuberculosis infection Year: 2014 Previous pneumococcal polysaccharide vaccine impacts immune response to subsequent pneumococcal conjugate vaccine in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 673s Year: 2005 In vitro immune response to Mycobacterium tuberculosis antigens Source: Eur Respir J 2005; 26: Suppl. 49, 22s Year: 2005 Humoral immune response to recombinant and native mycobacterial antigens in different forms of pulmonary tuberculosis (TB) in adults (A) and children (C) Source: Eur Respir J 2004; 24: Suppl. 48, 32s Year: 2004 Therapeutic effect of adenoviral vector-mediated GM-CSF gene transfer in lung antimycobacterial immunity in M. bovis BCG infected mice Source: International Congress 2016 – Rifampicin resistance, MDRTB, and new drug treatments Year: 2016 IgG-mediated humoral immune response against different mycobacterial antigens in tuberculosis (TB) and mycobacterial infections other than tuberculosis (MOTT) Source: Eur Respir J 2001; 18: Suppl. 33, 307s Year: 2001